Neuronal calcium sensor proteins are unable to modulate NFAT activation in mammalian cells  by Fitzgerald, Daniel J. et al.
Available online at www.sciencedirect.com
1780 (2008) 240–248
www.elsevier.com/locate/bbagenBiochimica et Biophysica ActaNeuronal calcium sensor proteins are unable to modulate NFAT
activation in mammalian cells
Daniel J. Fitzgerald 1, Robert D. Burgoyne, Lee P. Haynes⁎
The Physiological Laboratory, School of Biomedical Sciences, University of Liverpool, Crown Street, Liverpool, L69 3BX, UK
Received 8 August 2007; received in revised form 1 October 2007; accepted 18 October 2007
Available online 25 October 2007
Abstract
Calcium activated gene transcription through Nuclear Factor of Activated T-cells, (NFAT) proteins, is emerging as a ubiquitous mechanism for
the control of important physiological processes. Of the five mammalian NFAT isoforms, transcriptional activities of NFATs 1-4 are stimulated by
a calcium driven association between the ubiquitous phosphatase calcineurin and the calcium-sensing protein calmodulin. Published in vitro
evidence has suggested that other members of the calmodulin super-family, in particular the neuronal calcium sensor (NCS) proteins, can similarly
modulate calcineurin activity. In this study we have assessed the ability of NCS proteins to interact directly with calcineurin in vitro and report a
specific if weak association between various NCS proteins and the phosphatase. In an extension to these analyses we have also examined the
effects of over-expression of NCS-1 or NCS-1 mutants on calcineurin signalling in HeLa cells in experiments examining the dephosphorylation of
an NFAT-GFP reporter construct as a readout of calcineurin activity. Results from these experiments indicate that NCS-1 was not able to detectably
modulate calcineurin/NFAT signalling in a live mammalian cell system, findings that are consistent with the idea that calmodulin and not NCS-1 or
other NCS family proteins is the physiologically relevant modulator of calcineurin activity.
© 2007 Elsevier B.V. Open access under CC BY license.Keywords: NCS family proteins; Calmodulin; Calcineurin activity; NFAT signaling1. Introduction
Calcineurin (CN) [1] is a serine/threonine specific protein
phosphatase present in all eukaryotes that is responsible for the
modulation of numerous cell signalling pathways. Calcineurin
interacts with the ubiquitous EF-hand containing calcium (Ca2+)
sensor calmodulin (CaM) [2] and this obligate association drives
calcium dependent phosphatase activity, one of the primary
cellular targets of which are the Nuclear Factor of Activated T-cellAbbreviations: Ca2+, calcium; NFAT, Nuclear Factor of Activated T-cells;
NCS, Neuronal Calcium Sensor; CaBP1, Calcium Binding Protein-1; CaM,
Calmodulin; CN, Calcineurin; GST, Glutathione-S-transferase; KChIP1,
Potassium Channel Interacting Protein-1; GFP, Green Fluorescent Protein;
SDS, Sodium Dodecyl Sulphate; PAGE, Polyacrylamide Gel Electrophoresis;
HRP, Horse Radish Peroxidase; HEPES, 4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid; EDTA, Ethylenediaminetetraacetic acid; EGTA, Ethylene
glycol-bis(2-aminoethylether)-N,N,N′N′-tetra-acetic acid; NTA, N,N-Bis(car-
boxymethyl)glycine; PMA, Phorbol 12-myristate 13-acetate
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Open access under CC BY license.(NFAT) family of transcription factors. This family of gene
regulatory proteins is composed of fivemembers (NFAT1-5) [3,4],
that were first identified as fundamental components of the re-
combinatorial immune system of vertebrates [5], but which have
now been implicated in a far broader range of diverse and im-
portant physiological processes. Expression of NFAT proteins is
not restricted to cells of the immune system, demonstrated by their
presence and effect on key functions in a selection of other cell and
tissue types including brain and muscle. In a neuronal setting,
NFATs have been implicated in axonal remodelling, synaptic
plasticity and memory function [6-9]. Transcriptional events me-
diated by activated NFATs have been linked to aspects of car-
diovascular development [10,11] and they have also been
suggested to drive proliferative and apoptotic pathways in epi-
thelial cells, fibroblasts, pre-adipocytes, pancreatic β-cells and
osteoblasts [12-16]. The discovery that NFAT proteins can
influence cell cycle regulation has led to the proposal that they
may also be involved in certain aspects of tumorigenesis [17].
NFAT proteins in unstimulated cells are heavily phosphory-
lated onmultiple serine residues by of a number of constitutively
active kinases [18]. This modification acts to mask a nuclear
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predominantly cytosolic and transcriptionally inactive. Stimula-
tion of cells with agonists coupled to the phospholipase-C/IP3
generating pathway, depletion of endoplasmic reticulum Ca2+
stores and subsequent sustained elevation of intracellular Ca2+
concentration ([Ca2+]i) due to opening of plasma membrane Ca
2+
release activated Ca2+ channels elicits the rapid dephosphoryla-
tion of NFAT proteins, their nuclear import and upregulation of
target gene expression [3]. Under such circumstances, the Ca2+
signal is integrated upstream of NFAT by CN in conjunction with
CaM and it is this protein complex that represents the critical
regulatory mechanism for NFAT dephosphorylation and hence
activation of NFAT dependent gene expression. The relationship
between CN/CaM and NFATs is so deeply intertwined that
nuclear translocation of NFAT proteins has been employed as a
robust assay of CN activity in intact mammalian cells [19-21] and
has even found application in large scale screens for proteins
involved in calcium induced calcium release [22].
CaM is the primordial member of a superfamily of small EF-
hand containing Ca2+ binding proteins that function to transduce
spatial and temporal cellular Ca2+ signals. Other members of the
CaM family include the neuronal calcium sensor (NCS) sub-
group of neuronal/neuroendocrine specific proteins [23,24].
Although only distantly related (21% sequence identity between
CaM and NCS-1) published in vitro studies have identified
potential overlap in target protein interactions between CaM and
NCS-1 including an apparent positive interaction of both
proteins with CN [25]. Since CaM exhibits high and ubiquitous
expression these observations led to the speculation that NCS
proteins may simply represent redundant or alternative mod-
ulators of classical CaM targets. Evidence from our laboratory
and others has gone some way to disproving this idea with the
identification of NCS specific binding proteins that, at present,
have no documented interaction with CaM [26]. Further evi-
dence for distinct functionality of the NCS protein family is
apparent from their higher Ca2+ affinity compared to CaM, their
differential cellular/tissue distributions and their non-redun-
dancy revealed in genetic studies [23,27]. Together these data
indicate that NCS proteins possess the requisite biochemical
properties to allow them respond to unique Ca2+ signals and to
bind to distinct effector proteins. The possibility exists however
that overlap between CaM and NCS target specificities may be
of physiological significance and in the case of CN, identifica-
tion of a functionally relevant interaction with NCS proteins
would be of great interest in view of recent findings implicating
CN activity in aspects of neuronal function.
In order to resolve some of the outstanding questions con-
cerning potentially redundant functions of NCS proteins we have
examined whether or not they are able to elicit CN activation in
the physiologically relevant setting of intact mammalian cells
using NFAT activation as a coupled reporter. We present in vitro
biochemical data indicating that various recombinantly expressed
NCS family members are able to directly bind CN although to
lower levels compared with CaM. Consistent with these data we
have also determined that expression of NCS-1, mutants of this
protein that have previously been demonstrated to disrupt NCS-1
function in vivo, along with other NCS family members have noeffect on NFAT dephosphorylation in live HeLa cells in response
to elevation of [Ca2+]i. These data are supported by studies
indicating that the nuclear translocation of NFAT on elevation of
[Ca2+]i to cell nuclei is unaffected in cells expressing NCS-1 or
NCS-1 mutants. We therefore suggest that NCS proteins, al-
though exhibiting a detectable in vitro affinity for CN, may not be
likely to act as physiologically relevant modulators of CN activity
or NFAT mediated gene transcription in intact cells.
2. Materials and methods
2.1. Recombinant proteins
All recombinant GST fusion proteins used in this study were expressed and
purified as previously described [26]. Purified recombinant calcineurin was
obtained from Sigma (Poole, UK) or Biomol (Exeter, UK). Unless otherwise
stated all chemicals were of analytical grade and obtained from Sigma.
2.2. Small Scale GST protein binding assays
In all binding assays, recombinant GST-fusions proteins (1 μM) were
immobilised by incubation with 40 μl of glutathione cellulose (GST cellulose)
resin (50% bead slurry, Bioline, London, UK) that had been pre-washed in
binding buffer (KCl 50 mM, HEPES 20 mM (pH 7.4), EGTA 5 mM, NTA
5 mM, CaCl2 4.6 mM (giving a free [Ca
2+] of 1 μM)) (+Ca2+ conditions) or
binding buffer with no added CaCl2 (- Ca
2+ conditions) by incubation with
constant agitation for 30 min/4 °C. Recombinant calcineurin (1 μM) or bovine
brain cytosol (∼1 mg, dialysed against the appropriate±Ca2+ binding buffer)
were then added to immobilised GST proteins in a 100 μl total binding reaction
volume and samples incubated with constant agitation for 2 hrs at 4 °C. GST
cellulose beads were pelleted by centrifugation (5,000 rpm/1 min/4 °C) and
washed with 1 ml of the appropriate binding buffer. This wash step was repeated
three times and final bead pellets extracted into 50 μl SDS dissociation buffer
(125 mM HEPES pH (6.8), 10% (v/v) sucrose, 10% (v/v) glycerol, 4% (w/v)
SDS, 1% β-mercaptoethanol, 2 mM EDTA) and boiling for 5 min. Samples
were resolved on SDS-PAGE (12.5% gel) and transferred to nitrocellulose filters
for western blotting by transverse electrophoresis. Bound calcineurin was de-
tected using a monoclonal antibody (1:1000, Sigma) followed by incubation
with anti-mouse-HRP (1:400, Sigma) and visualisation with ECL reagents. All
western blots were quantitated using ImageJ (National Institutes of Health)
densitometry software.
2.3. Large scale GST protein binding assays
This binding assay is essentially as described in [26]. Briefly, each recom-
binant GST-fusion protein (5–10 mg), including free GST as control, was
immobilised onto 3 ml glutathione-Sepharose 4B resin that had been pre-washed
extensively with binding buffer by incubation for 2 h at 4 °C with constant
agitation. Clarified bovine brain cytosolic extract was applied to the GSTaffinity
columns and binding allowed to proceed for 16 h at 4 °C with constant agitation.
Each column was washed with a minimum 50 volumes of binding buffer and
specific Ca2+-dependent binding proteins eluted using binding buffer containing
no added Ca2+(calcium-free or CF buffer). An additional high-salt elution step
with binding buffer supplemented with 1 M NaCl and no added Ca2+ (High Salt
or HS buffer) was used to isolate potential Ca2+-independent binding inter-
actions. Eluted protein fractions were concentrated by methanol precipitation
and pellets extracted into SDS dissociation buffer by boiling for 5 min. All
western blots were quantitated using ImageJ (National Institutes of Health)
densitometry software.
2.4. Sulfo-SBED cross-linking experiments
The manufacturers protocol provided by Pierce (Rockford, IL, USA) was
followed with minor modifications. All steps, except those indicated, were
carried out in the dark. Bait recombinant protein of interest (∼5mg) was dialysed
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one tube of No-Weigh Sulfo-SBED (Pierce) was dissolved in 22 μl of DMSO,
this was then added to 1 ml of dialysed protein. Sulfo-SBED/protein mixes were
incubated at room temperature for 30 minutes, centrifuged briefly to remove any
precipitated, hydrolysed, Sulfo-SBED, and dialysed overnight against binding
buffer. Bovine brain cytosol (500 μl, ∼4 mg protein) dialysed against binding
buffer was added to 500μl of the Sulfo-SBED/protein mix. This mixture was
incubated on a rotator at room temperature for 1 hour. After this step, samples
were exposed to long-wave UV illumination (365 nm) at a distance of ∼5 cm
from source for 15 minutes. During this step an appropriate volume of Neu-
travidin beads (Pierce) were washed extensively in binding buffer, 100 μl added
to the bait/cytosol mixture and samples incubated on a rotator for 1 hour at room
temperature. Bait/cytosol mixes were then centrifuged at 13,000 rpm for 1 minute,
supernatants removed and beads washed with 1 ml of binding buffer. This stepwas
repeated 6 times. Disulfide bond reduction was then achieved by incubating with
1 ml of 50 mM DTT for 1 hour at room temperature. Beads were subsequently
centrifuged and washed extensively with binding buffer. After the final wash,
100 μl of SDS dissociation buffer was added to the beads and samples boiled for
10 minutes. Samples were separated on SDS PAGE (12.5% gel) and western
blotted with a monoclonal anti-calcineurin antibody (1:1000, Sigma) followed by
detection with anti-mouse-HRP (1:400, Sigma) and ECL reagents.
2.5. HeLa cell cultures and transfections
HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen, Paisley, UK) containing 5% foetal bovine serum (Invitrogen), 1% non-
essential amino acids (Invitrogen), and 1% penicillin/streptomycin (Invitrogen) at
37 °C in an atmosphere of 5%CO2 andmaintained at∼1,000,000 cells per 75 cm2
flask. 24 hrs prior to transfection, cells were seeded onto glass cover slips on a 24-
well plate at ∼50,000 cells per well. Transfection mixtures comprised 3 μl
Fugene™ (Roche, UK) per 1 μg plasmid DNA in a 100 μl total volume of DMEM
and were incubated at room temperature for 30 minutes prior to being added drop-
wise to cells. Cells were assayed 24-48 hrs post-transfection. The NFAT-GFP
reporter construct was a kind gift from Professor Anjana Rao (Harvard Medical
School, Boston, MA, USA).
2.6. Ionomycin induced NFAT translocation
Transfected HeLa cells were washed twice in Krebs buffer (NaCl 145 mM;
HEPES 20 mM (pH 7.4); D-(+)-Glucose 10 mM; KCl 5 mM; CaCl2 3 mM;
MgCl2 1.3 mM; NaH2PO4 1.2 mM). Cells were subsequently incubated in
500 μl Krebs containing 3 μM ionomycin or 100 μM histamine for required
times before either solubilisation in SDS dissociation buffer, to investigate the
phosphorylation state of NFAT via Western blotting, or fixing in 4% for-
maldehyde to observe the resulting sub-cellular localisation of NFAT post-
treatment via confocal microscopy. For western blotting all samples were re-
solved on SDS-PAGE (12.5% gel) and proteins transferred to nitrocellulose
filters by transverse electrophoresis. Filters were probed with monoclonal anti-
GFP (1:1000, JL-8 clone, Invitrogen) followed by incubation with anti-mouse-
HRP (1:400, Sigma) and protein visualised with ECL reagents.
2.7. Confocal microscopy
For confocal laser scanning microscopy, transfected cells were examined
with either a Leica TCS-SP-MP microscope or a Leica TCS-SP2-AOBS mi-
croscope (Leica Microsystems, Heidelberg, Germany) using a 22 μm pinhole
and a 63× water immersion objective with a 1.2 numerical aperture. EGFP was
imaged using excitation at 488 nm and light collection at 500-550 nm.3. Results
3.1. Direct binding of calcineurin to NCS proteins
A previous in vitro study demonstrated that NCS-1 is cap-
able of stimulating the phosphatase activity of CN but did notexamine whether the two proteins directly associate. To confirm
a direct interaction we first performed a series of in vitro binding
assays utilising various recombinantly expressed and purified
NCS proteins to act as baits and where either purified recom-
binant CN or bovine brain cytosol were employed as a source of
prey protein. Initially, purified CN (1 μM) was incubated in the
presence of various GST-tagged NCS proteins (also at 1 μM) in
binding buffer containing 1 μM free Ca2+ (Fig. 1a, upper panel).
CaM was included in this assay as a positive control for CN
binding (Fig. 1a, upper panel, Calmodulin Sepharose). CN was
observed to bind directly to GST-NCS-1, GST-Hippocalcin,
GST-Neurocalcin-δ and GST-CaBP1 but not GST-KChIP1,
despite equal loading of the proteins (Fig. 1a, lower panel),
indicating some degree of interaction specificity. It was also
apparent from this analysis that, under identical experimental
conditions, seven-fold less CN was bound by GST-tagged NCS
proteins than by CaM. We next examined if GST-tagged NCS
proteins could efficiently interact with CN present as a com-
ponent of a complex protein mixture. GSTcontrol protein, GST-
NCS-1 and GST-CaBP1 (Calcium Binding Protein-1, a calcium
sensor more closely related to CaM than the NCS family pro-
teins [28]) were incubated with bovine brain cytosolic protein
extract in a large scale pull-down experiment [26] in the pre-
sence of 1 μM free Ca2+ and Ca2+ dependent binding partners
eluted by application of Ca2+ free buffer containing EGTA and
NTA (Fig. 1b, Calcium Free (CF) lanes). An additional elution
step using 1 M NaCl supplemented buffer was also applied to
the samples to elute potential Ca2+ independent binding pro-
teins (Fig. 1b, High Salt (HS) lanes). Western blotting for the
presence of CN in eluates confirmed a strictly Ca2+ dependent
interaction with both GST-NCS-1 and GST-CaBP1. No binding
was detectable to GST control protein. The signal for CN in the
bovine brain cytosolic extract was compared in the same expe-
riment (Fig. 1b, Bovine brain cytosol) and it was clear that CN
was not enriched over the brain extract in the Ca2+ free eluates.
To provide an independent method to examine the interac-
tion between NCS proteins and CN, we exploited a recently
developed bi-functional cross-linking reagent [29] which per-
mits the transfer of a biotin tag from a bait protein of interest to
any specifically interacting prey proteins captured following a
binding reaction. Samples from a GST-Neurocalcin-δ binding
assay prepared via this method were probed with an anti-CN
antibody and the presence of the phosphatase confirmed only in
samples treated with the cross-linker (Fig. 1c, (+) Sulfo) and no
CN was detectable in samples devoid of the reagent (Fig. 1c, (-)
Sulfo). Despite use of cross-linking to maintain any low affinity
interactions, CN was not enriched in the eluate over brain
cytosol input into each condition (Fig. 1c (+) Sulfo vs. Bovine
brain cytosol).
The data presented in Fig. 1a suggests that the affinity of CN
for CaM may be substantially greater than for the NCS proteins
tested. In order to independently verify these observations we
further examined the binding of CN from bovine brain cytosol to
GST control protein and GST-NCS-1 in direct comparison to
CaM (Fig. 1d). We observed Ca2+ dependent binding of CN to
CaM (Fig. 1d, Calmodulin Sepharose (+)) that was significantly
enriched in the eluate compared to bovine brain cytosolic extract,
Fig. 1. NCS proteins interact with calcineurin in vitro. (a) Upper Panel, Anti-
calcineurin western blot of samples from an in vitro binding assay examining
interaction of recombinant CN (1 μM) with various GST-tagged NCS proteins
(all at 1 μM) and to calmodulin sepharose (1 μM) in the presence of buffer
containing 1 μM free Ca2+. CN was associated directly with calmodulin
sepharose and to a lesser extent with GST-NCS-1, GST-Hippocalcin, GST-
Neurocalcin-δ and GST-CaBP1 but not with GST-KChIP1. (a) Lower panel,
coomassie blue stained gel highlighting equal loading of GST fusion proteins
input into the binding assay. (b) Anti-calcineurin western blot of samples from
an in vitro binding assay examining the ability of CN derived from bovine brain
cytosolic extract to associate with GST control and GST-NCS proteins in both
the absence (High Salt or HS) and presence (Calcium Free or CF) of 1 μM free
Ca2+. CN was detectable bound to both GST-NCS-1 and GST-CaBP1 only in the
presence of free Ca2+ and no CN was present in HS samples or GST control
protein samples either in the presence or absence of Ca2+. The amount of CN in
the bovine brain cytosolic extract was shown in a positive control sample of total
brain cytosolic lysate resolved on the same gel (Bovine brain cytosol). (c) Anti-
calcineurin western blot of samples obtained from a Sulfo-SBED cross-linking
experiment (see Materials and Methods for details). CN was detectable in
samples from a GST-neurocalcin-δ affinity column treated with the biotin
transfer reagent ((+) Sulfo) but not in its absence ((-) Sulfo). Input bovine brain
cytosolic extract was resolved on the same gel (Bovine brain cytosol). (d) Anti-
calcineurin western blot on samples from in vitro binding experiments involving
incubation of bovine brain cytosolic protein extract with GST control protein,
calmodulin sepharose and GST-NCS-1 (all at 1 μM) in the absence (-) or
presence (+) of 1 μM free Ca2+. Total bovine brain cytosolic protein extract was
separated on the same gel as a positive control for CN.
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NCS-1 was barely detectable. On longer exposure to film, NCS-1
bound CN was detectable although it should be noted that results
obtained from this small scale binding assay are not directly
comparable to data presented in Fig. 1b from a large scale binding
assay which employed a greater amount of bovine brain cytosolic
prey protein. These data are consistent with a high affinity Ca2+
dependent interaction between CaM and CN in contrast to a
comparatively weak interaction between NCS-1 and CN.
3.2. Overexpression of NCS proteins has no effect on the
dephosphorylation of anNFAT-GFP reporter construct in response
to cytosolic Ca2+ elevation in HeLa cells
Although our in vitro studies pointed to CaM asmost likely the
predominant interacting/activating partner for CN, we speculated
that the situation in the complex physiological setting of mam-
malian cells might not reflect the results obtained from such a
comparatively simple analysis. We therefore attempted to resolve
this issue through an examination of a possible interaction bet-
ween CN and NCS proteins in intact HeLa cells. For these
experiments we obtained a GFP tagged NFAT reporter construct
[30], encoding the phosphorylated regulatory domain of the
phosphatase, that undergoes a detectable dephosphorylation and
nuclear translocation in response to sustained increases in [Ca2+]i.
Our rationalewas that should there be a functionally relevantNCS
protein/CN interaction in cells then there might be discernable
alterations in dephosphorylation kinetics/nuclear translocation of
the NFAT reporter in cells [30,31] over-expressing NCS proteins
as observed for other NCS-1 specific functions [32-35].
In initial studies, we saw no effect on NFAT dephosphoryla-
tion or nuclear translocation of over-expression of wild-type
NCS-1, hippocalcin or neurocalcin-δ. Since NCS-1 had been
identified in a previous report [25] as an in vitro activator of CN
enzymatic activity we decided, however, to focus on this NCS
family member for this part of the study. A second reason for
examining NCS-1 in further detail also related to the fact that we
had at our disposal several mutant NCS-1 constructs one of
which has been previously characterised as a dominant inhibitor
of NCS-1 function [32]. Suchmutants, we reasoned, might assist
in unmasking potential functional interactions between NCS-1,
CN and NFAT. The first of these mutants, NCS-1E120Q, has been
employed in a number of studies due to its ability to interact
normally with NCS-1 effectors however, as a consequence of
impaired Ca2+ binding and conformational change, it can then
exert a dominant inhibitory phenotype [32-36]. The second
NCS-1 mutant we employed in this study, NCS-1G2A, is my-
ristoylation deficient and, unlike wild type NCS-1 which is
constitutively membrane associated through this lipid modifica-
tion, is entirely cytosolic [37,38]. This protein was included in
these studies due to the fact that the majority of cellular CN is
similarly cytosolic and hence we hypothesised that the G2A
mutation may exaggerate any effects of a potential NCS-1/CN
interaction.
In an initial analysis, HeLa cells were co-transfected with
NFAT-GFP along with control empty vector, NCS-1 or NCS-1
mutant constructs (Fig. 2a). Cells were treated for 7 minutes
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detected by western blotting. A band corresponding to the fully
phosphorylated form of NFAT was apparent in 0 time point
samples from all transfections (Fig. 2a, P, upper arrow). De-
phosphorylation of NFAT to two more rapidly migrating species
after sustained [Ca2+]i for 7 minutes was observable in all
transfected samples and there was no detectable difference in
the dephosphorylation pattern obtained between control trans-
fected cells and NCS-1 or NCS-1 mutant transfected conditions
(Fig. 2a, DeP, lower arrows). These data are fully consistent
with results obtained from parallel confocal imaging analyses of
NFAT-GFP nuclear translocation in HeLa cells transfected and
treated in an identical manner but which were then fixed for
microscopy (Fig. 2b). For all transfection conditions at time 0 of
Ca2+/ionomycin treatment NFAT-GFP was excluded from cell
nuclei and was diffusely cytosolic (Fig. 2b, control, left hand
panels), compatible with the presence of the phosphorylatedform of the protein (Fig. 2a). After 7 minutes of Ca2+/ionomycin
treatment NFAT-GFP had redistributed to cell nuclei for all
transfection conditions (Fig. 2b, ionomycin, right hand panels)
again consistent with the rapid dephosphorylation of the protein
(Fig. 2a).
We additionally verified that all NCS-1 expression con-
structs used in these studies over-expressed in HeLa cells to
similar extents when co-expressed with NFAT-GFP (Fig. 2c).
Western blotting with an anti-NCS-1 antiserum [39] of total cell
lystates from HeLa cells transfected identically to those used
in functional assays (Figs. 2a and b) highlighted essentially
equivalent levels of over-expression of NCS-1, NCS-1G2A and
NCS-1E120Q proteins. There was no detectable NCS-1 protein
expression in control, pcDNA transfected, cells (Fig. 2c, pcDNA).
3.3. Overexpression of NCS-1, NCS-1E120Q and NCS-1G2A has
no effect on the dephosphorylation of an NFAT-GFP reporter
construct in response to cytosolic Ca2+ elevation in HeLa cells
over an acute time course
Our analyses suggested that, over a 7 minute time course,
none of the NCS-1 constructs under examination were capable
of affecting the dephosphorylation of NFAT-GFP in response to
[Ca2+]i elevation and, by inference, nor were they able to
influence CN activity in intact mammalian cells. These whole
cell data were consistent with our in vitro binding studies
however we decided to complete our investigation with two
further analyses, firstly examining whether or not NCS-1 might
exert a far more subtle effect on the CN/NFAT pathway over an
acute time course of [Ca2+]i elevation (Fig. 3a). In these
experiments, HeLa cells were again transfected with NFAT-GFP
along with control or NCS-1 expression constructs however
dephosphorylation was monitored over a short 5 minute time
course. For all constructs tested NFAT dephosphorylation wasFig. 2. Over-expression of NCS-1 and NCS-1 mutant proteins has no detectable
effect on NFAT dephosphorylation or NFAT nuclear translocation. (a) Anti-GFP
western blot analysis of samples from HeLa cells co-transfected with an NFAT-
GFP reporter construct in addition to control empty vector (pcDNA) or the
indicated pcDNA based NCS-1 expression constructs. Cells were treated with
Ca2+/ionomycin for the indicated times and lysed for SDS-PAGE analysis/
western blotting with anti-GFP antibody. Fully phosphorylated NFAT-GFP was
detectable in all transfection conditions at the zero time point (P, upper arrow)
and dephosphorylation of this reporter was clearly observable after 7 mins of
Ca2+/ ionomycin treatment with a gel shift to two more rapidly migrating species
corresponding to dephosphorylated forms of the protein (DeP, lower arrows).
(b) Confocal images of NFAT-GFP fluorescence from HeLa cells transfected and
treated as for (a) but subsequently fixed and processed for microscopy. NFAT-
GFP fluorescence was diffusely cytosolic and excluded from cell nuclei under
control, zero time point, conditions for all transfected constructs tested. On
elevation of cytosolic Ca2+ for 7 mins (ionomycin) NFAT-GFP fluorescence was
observed to translocate from the cytosol to cell nuclei for all transfected con-
structs analysed, consistent with dephosphorylation of the protein observed in
parallel western blot studies (a). Scale bars 10 μm. (c) Western blot of total HeLa
cell lysates with an anti-NCS-1 antiserum. Cells transfected identically to those
used in functional assays (a and b) were lysed and subjected to western blotting
to determine relative over-expression levels of the NCS-1 proteins analysed in
this part of the study. Essentially equivalent levels of expression were detected
for NCS-1, NCS-1G2A and NCS-1E120Q constructs. No NCS-1 signal was
detectable in control empty vector transfected samples (pcDNA).
Fig. 3. NCS-1 and NCS-1 mutant proteins do not affect dephosphorylation of NFAT-GFP over an acute time course of intracellular Ca2+ elevation. (a) Anti-GFP
western blots on HeLa cell lysates from cells transfected with NFAT-GFP and the indicated pcDNA based expression constructs. Cells were treated with Ca2+/
ionomycin for the indicated times and then lysed directly into SDS dissociation buffer, separated on SDS-PAGE (12.5% gel) and transferred to nitrocellulose for
western blotting with an anti-GFP antibody. Fully phosphorylated NFAT-GFP (P, upper arrow) present at time 0 for all transfection conditions was dephosphorylated
on Ca2+/ionomycin treatment as monitored by the appearance of more rapidly migrating species by the 5 min time point for all transfection conditions (De-P, lower
arrow). (b) Anti-calcineurin western blot on samples derived from an in vitro binding assay where recombinant CN (1 μM) was incubated with GST control protein,
GST-NCS-1 or GST-NCS-1E120Q (all at 1 μM) in the absence (-Ca2+) or presence (+Ca2+) of 1 μM free Ca2+. Samples from duplicate incubations are presented.
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point was also included to demonstrate complete dephospho-
rylation of NFAT-GFP) as determined by gel shift of the NFAT-
GFP. Analysis of these earlier time points indicated there was no
discernable difference in the pattern of dephosphorylation bet-
ween any of the NCS-1 constructs tested and control transfected
cells.
In these experiments the calcium induced elevation in cyto-
solic free Ca2+ was artificially generated by high concentrations
of ionomycin and external Ca2+. Since NCS-1 has a high
affinity for Ca2+ (300 nM) one possibility is that it could
activate CN under conditions of limited Ca2+ elevation thus
increasing the overall cellular sensitivity to a Ca2+ signal. We
completed, therefore, our analyses with an examination as to
whether over-expression of NCS-1 or its mutants could in-
fluence NFAT dephosphorylation in response to a physiological
stimulus. Histamine is a well characterised HeLa cell agonist
that generates oscillatory intracellular Ca2+ signals [40] and
activation of protein kinase C with phorbol esters has been
shown to potentiate NFAT driven gene expression elicited by
such Ca2+ oscillations [41-43]. We stimulated HeLa cells trans-
fected identically to those in Figs. 2 and 3 with 100 μM his-
tamine in both the presence and absence of 50 nM PMA over a
three hour time course and assessed the phosphorylation state
of NFAT-GFP by western blotting. No dephosphorylation of
NFAT-GFP was detectable in these experiments in control vec-tor expressing cells indicating that the stimulus was below the
threshold for activation of CN/NFAT-GFP dephosphorylation.
Significantly, cells expressing NCS-1, NCS-1E120Q or NCS-1G2A
also failed to exhibit dephosphorylation of NFAT-GFP indicating
that over-expression of NCS-1 did not enhance the sensitivity of
the CN/NFAT signalling pathway to Ca2+ signals under these
conditions (data not shown).
For NCS-1E120Q to be able to exert a dominant negative effect
it would have to bind to CN. In order to validate our use of the
NCS-1E120Q mutant as a dominant negative construct in this study
we therefore generated a recombinantly purified GST-tagged
fusion construct encoding this protein which was used to confirm
its ability to bind to purified CN (Fig. 3b). GST-NCS-1E120Q
retained almost wild-type CN binding activity in this assay
although with less strict Ca2+-dependency validating its use in
functional assays of NFAT dephosphorylation and nuclear trans-
location. For GST-NCS-1 we observed a 13.7-fold increase in
binding of CN in the presence of Ca2+ compared to conditions
where Ca2+ was absent. In contrast, there was only a 2.2-fold
increase in CN binding to GST-NCS-1E120Q in the presence of
Ca2+.
4. Discussion
Diverse Ca2+ signals are transduced and decoded within cells
by a variety of Ca2+-sensing proteins. Of these Ca2+ responsive
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calmodulin (CaM) [2]. CaM is the prototypical member of a
super-family of evolutionarily diverse EF-hand containing Ca2+
sensors to which the NCS sub-family belongs [23]. Whilst the
NCS proteins are only distantly related to CaM, comparative
studies have identified significant in vitro overlap in their ef-
fector specificities [25]. It was proposed that NCS proteins
might represent a set of redundant or alternative modulators of
bone fide CaM target interactions [25] but the ubiquitous and
high level expression of CaM would make this doubtful.
Calcineurin (CN) is a cellular serine/threonine phosphatase
critical to the activation of NFAT transcription factors and hence
in the control of a variety of fundamental physiological pro-
cesses [3]. CaM has been identified as the essential co-activator
for CN function, however CN has also been identified as a
potential target for NCS-1 [25] and as such represents a can-
didate dual CaM/NCS effector.
A series of possibilities exist as a direct consequence of these
observations. Firstly, NCS proteins could indeed simply re-
present redundant modulators for CaM targets and as such
might be expected to elicit responses and to exhibit biochemical
properties closely approximating those observed with CaM.
Secondly, NCS proteins could feasibly interact with CaM
targets in biochemically distinct ways to modulate their ac-
tivities in specific, CaM independent, manners leading to the
overall generation of unique physiological endpoints. The latter
has been suggested for dual regulation of voltage-gated Ca2+-
channels by both CaBP1 and CaM [44]. With specific regard to
possible CN/NFAT activation by NCS-1, this possibility is
intriguing in light of data identifying NFAT dependent gene
expression as important to aspects of neuronal cell function.
Thirdly, the possibility also exists that interactions observed
between NCS proteins and CaM targets are physiologically
irrelevant in cells. In this study we have attempted to resolve
these issues through an investigation of firstly the biochemical
characteristics of NCS protein interactions with CN, and
secondly by examining the potential consequences of NCS
protein function on activation of the classical CaM-CN-NFAT
pathway in mammalian cells.
In a series of in vitro biochemical assays we were able to
show that there exists a selective and Ca2+ dependent in-
teraction between various NCS proteins and both purified
recombinant CN, and CN derived from bovine brain cytosolic
protein extract. We noted during these analyses however that
significantly more CN bound to immobilized CaM. These data
are consistent with the findings of Schaad et al. indicating that
NCS-1 is able to stimulate the phosphatase activity of CN in
vitro but to a lesser extent than observed for CaM activation. In
experiments utilising bovine brain cytosol as a source of prey
protein the difference in binding of the NCS proteins for CN in
comparison to CaM was more greatly magnified, and whilst
considerable quantities of CN could be affinity purified by a
calmodulin sepharose column, the amount of CN associated
with NCS family members under identical experimental
conditions was considerably lower. Previous work using a
biotinylated protein overlay assay also found much less binding
of CN to NCS-1 compared to CaM [45]. These data led us toconclude that the CaM/CN interaction was likely to be of a
higher affinity than for interactions between CN and NCS
proteins. Indeed, published biochemical parameters suggest that
the in vitro Kd for CaM/CN interaction may be ≤0.1 nM [46]
with that reported for NCS-1/CN being 350 nM [25]. The in
vitro affinity of CaM for CN is therefore three orders of mag-
nitude greater than that determined for NCS-1 which would
agree with the binding data presented in this study. Importantly,
CaM is expressed at 5-200 fold higher concentrations in cells
than NCS-1 [25] and so CN would be predicted to be bound to
CaM rather than NCS-1 at elevated [Ca2+]i levels.
To assess whether NCS proteins were capable of modulating
CN activity in a cellular environment we employed the de-
phosphorylation and nuclear translocation of a characterised
NFAT-GFP reporter construct as a probe of CN phosphatase
activity. Co-expression of NCS-1 did not alter the basal phos-
phorylation state of NFAT-GFP compared with control
transfected cells nor did it exert a detectable effect on NFAT-
GFP dephosphorylation/nuclear translocation after sustained
elevation of [Ca2+]i during single endpoint and acute time
course analyses. Co-expression of the NCS proteins Hippocal-
cin, Neurocalcin-δ [26], and the more closely related CaBP1
(which shares 56% similarity with CaM [47]) were similarly
without effect in analyses of NFAT-GFP dephosphorylation
(data not shown). From these analyses we cannot formally
exclude the possibility that NCS family proteins may activate a
pool of cellular CN that does not signal via NFAT depho-
sphorylation. This seems unlikely however taking into account
our biochemical data and the fact that in numerous other studies
assessing diverse triggers of CN activity, concomitant activation
of the NFAT pathway is always detected.
In an extension to these studies we also examined the effects
of two NCS-1 mutant proteins, NCS-1E120Q and NCS-1G2A, on
NFAT-GFP dephosphorylation in HeLa cells. We were able to
demonstrate that the E120Q mutant of NCS-1 [32] retained
approximately wild type binding properties with respect to
interaction with purified CN. However, this protein, which has
been routinely observed to exert a dominant negative phenotype
in various other studies of NCS-1 function [32-35], was unable
to generate detectable alterations in NFAT-GFP dephosphoryla-
tion. In an effort to try and understand if NCS-1 was unable to
mediate an in vivo modulation of CN activity due to its res-
tricted membrane localisation we also examined NFAT-GFP
phosphorylation in the presence of co-expressed NCS-1G2A, a
protein that fails to become myristoylated and as a result
remains cytosolic. Since the bulk of cellular CN is also cytosolic
we reasoned that expression of the G2A mutant might bias any
interaction with CN to generate an observable alteration in
dephosphorylation of NFAT-GFP. Our analysis of this mutant
indicated that it elicited no significant change in the kinetics of
NFAT-GFP dephosphorylation compared to control transfected
cells. In related experiments we tested the ability of NCS-1 and
NCS-1 dominant inhibitory mutants to influence NFAT depho-
sphorylation in response to physiological stimuli. We observed
no detectable changes in NFAT dephosphorylation in the pre-
sence of over-expressed NCS-1 proteins suggesting that in
addition to sustained elevation of cytosolic free Ca2+, NCS-1
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tion in response to agonist derived Ca2+ signals that were
below the threshold for significant activation of CN and NFAT
dephosphorylation.
Collectively our findings would argue that, although NCS
proteins are capable of interacting with CN in vitro, they may be
unable to act as functionally relevant activators of the enzyme in
a cellular context. The possibility remains that there may be
some level of interplay between NCS proteins and CaM within
protein complexes, exemplified by observations that both CaM
and CaBP1 interact with IP3-receptors [40,48,49], that both
NCS-1 and CaM are able to interact with Ca2+ channels [50]
and G-protein coupled receptor kinases [34,51,52] and that
CaM, NCS-1 and CaBP1 have all been shown to modulate the
activity of the transient receptor potential channel, TRPC5 [35].
It is impossible to formally rule out direct modulation of CN by
NCS proteins under all physiological conditions based on the
data presented in this study however we have provided data to
challenge the idea that CN is a cellular target of the NCS protein
family and instead that CaM appears the more likely regulator
of this key signalling phosphatase.
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